Severe glomerulonephritis and encephalopathy associated with parvovirus B19 infection mimicking systemic lupus erythematosus

Scandinavian Journal of Rheumatology

Volumn 41, Issue 1, 2012, Pages 79-81

  Cugler, T ^a   De Carvalho, L M ^a   Facincani, I ^a   Yamamoto, A Y ^a   Silva, G E Barros ^a   Costa, R Silva ^a   Ferriani, V P L ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANOREXIA; ANTIBODY TITER; BLINDNESS; BRAIN VASOSPASM; CASE REPORT; CEREBROSPINAL FLUID CYTOLOGY; CHILD; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; ERYTHEMA INFECTIOSUM; FEMALE; FEVER; GLOMERULONEPHRITIS; HUMAN; HUMAN PARVOVIRUS B19; HUMAN PARVOVIRUS B19 INFECTION; HYPERTENSION; HYPERTENSION ENCEPHALOPATHY; KIDNEY BIOPSY; LABORATORY TEST; LETTER; MENTAL DISEASE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OTALGIA; PARVOVIRUS INFECTION; PERIPHERAL EDEMA; PETECHIA; POLYMERASE CHAIN REACTION; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SEIZURE; SORE THROAT; SYMPTOM; SYSTEMIC LUPUS ERYTHEMATOSUS; TEMPORAL LOBE EPILEPSY; VERTIGO; VIRUS STRAIN; VOMITING;

AUTOANTIBODIES; CHILD; DIAGNOSIS, DIFFERENTIAL; DNA, VIRAL; FEMALE; GLOMERULONEPHRITIS; HUMANS; HYPERTENSIVE ENCEPHALOPATHY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE IMAGING; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; POLYMERASE CHAIN REACTION; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84856475222     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2011.617315     Document Type: Letter

References (10)

1. Seve P, Ferry T, Koenig M, Cathebras P, Rousset H, Broussolle C. Lupus-like presentation of parvovirus B19 infection. Semin Arthritis Rheum 2004;34:642-8.
2. Waldman M, Kopp JB. Parvovirus B19 and the kidney. Clin J Am Soc Nephrol 2007;2:47-56.
3. Fawaz-Estrup F. Human parvovirus infection: rheumatic manifestations, angioedema, C1 esterase inhibitor deficiency, ANA positivity, and possible onset of systemic lupus erythematosus. J Rheumatol 1996;23:1180-5.
4. Sugimoto T, Tsuda A, Uzu T, Kashiwagi A. Emerging lupus-like manifestations in acute parvovirus B19 infection. Clin Rheumatol 2008;27:119-20. (Pubitemid 350182689)
5. Pruksachatkunakorn C, Apichartpiyakul N, Kanjanaratanakorn K. Parvovirus B19 infection in children with acute illness and rash. Pediatr Dermatol 2006;23:216-18. (Pubitemid 43886546)
6. Ramos-Casals M, Cuadrado MJ, Alba P, Sanna G, Brito-Zeron P, Bertolaccini L, et al. Acute viral infections in patients with systemic lupus erythematosus: description of 23 cases and review of the literature. Medicine (Baltimore) 2008;87:311-18.
7. McCoy B, King M, Gill D, Twomey E. Childhood posterior reversible encephalopathy syndrome. Eur J Paediatr Neurol 2011;15:91-4.
8. Hession MT, Au SC, Gottlieb AB. Parvovirus B19-associated systemic lupus erythematosus: clinical mimicry or autoimmune induction? J Rheumatol 2010;37:2430-2.
9. Lunardi C, Tinazzi E, Bason C, Docino M, Carrocher R. Human parvovirus B19 infection and autoimmunity. Autoimmunity Rev 2008;8:116-20.
10. Pavlovic M, Kats A, Cavallo M, Shoenfeld Y. Clinical and molecular evidence for association of SLE with parvovirus B19. Lupus 2010;19:783-92.